Authors:
DICOSTANZO F
SDROBOLINI A
MANZIONE L
BILANCIA D
DINOTA A
ROCCA A
GASPERONI S
GIUSTINI L
ACITO L
COLOZZA MA
GORI S
MOSCONI AM
CONTU A
Citation: F. Dicostanzo et al., MITOXANTRONE (M) AND TAXOL (T) AS FIRST LINE CHEMOTHERAPY IN PATIENTSWITH ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 111-111
Authors:
DICOSTANZO F
GASPERONI S
CARLINI P
TONATO M
LABIANCA R
BRAVI S
FORNARINI G
BISAGNI G
SDROBOLINI A
MANZIONE L
Citation: F. Dicostanzo et al., ADJUVANT CHEMOTHERAPY WITH PELF IN OPERABLE GASTRIC-CANCER - (STAGE IB, II, IIIA-B AND IV T4N2MO), Annals of oncology, 9, 1998, pp. 252-252
Authors:
DICOSTANZO F
GASPERONI S
MALACARNE P
BELSANTI V
LUPPI G
MARZOLA M
CORGNA E
SDROBOLINI A
PASSALACQUA R
FIGOLI F
ALGERI R
ZIRONI S
ANGIONA S
BONI C
Citation: F. Dicostanzo et al., HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL ALONE OR COMBINED WITH HYDROXYUREA IN ADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH, American journal of clinical oncology, 21(4), 1998, pp. 369-375
Authors:
DICOSTANZO F
SDROBOLINI A
MARZOLA S
ZIRONI S
CONTU A
PUCCI E
RODINO C
CORGNA E
ALGERI R
BISAGNI G
ANGIONA S
Citation: F. Dicostanzo et al., HYDROXYUREA (HU), HIGH-DOSE FOLINIC ACID (L-FA) AND 5FU VS HU, 5FU AND INTERFERON-ALFA-2B (IFN) IN ADVANCED COLORECTAL-CANCER (ACRC) - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), European journal of cancer, 31A, 1995, pp. 721-721